15 November 2018
Withings which has been facing a tumultuous couple of years has undercut Apple to launch a $129 ECG monitoring watch. Withings was bought by Nokia and was later re-acquired by its original owner Éric Carreel in May last year.
The company is known for its range of smart scales, thermometers, and other health electronics. The company has been facing an uphill battle in the wearable space. The company’s latest device is a $129 Withings Move ECG watch that targets those who want a more affordable device. The Withings Watch competes with the $350 Apple Watch which also offers the ECG function.
The Withings Move ECG has an analogue face and has three electrodes that measure electrocardiograms. Two of the electrodes are embedded into the body of the watch while the third sits in the watch's bezel. Users can take a reading by touching both sides of the bezel at the same time while wearing the watch and waiting for about 30 seconds.
The process is identical to that of the Apple Watch Series 4, which has one circular electrode on its underside and one smaller electrode on its Digital Crown. The watch comes with a Withings' Health Mate mobile app which allows you to see your heartbeat. the data accumulated over time by the watch can be seen in larger charts and graphs in the app and can be shared with caregivers. The Withings Move ECG is currently under review for FDA clearance.
The Move ECG also tracks a user’s daily activity and sleep, as well as step-count progress. It automatically detects and tracks activities including swimming. Users can use the GPS mode that allows you to map outdoor activities. The Withings Move ECG is priced at $129 and will be available in Q2 2019.